The Cancer Letter

Inside information on cancer research and drug development

Michelle Le Beau: CPRIT will be “looking at everything” through a health equity lens in awarding billions of dollars in grants

In Brief

Eric Winer to lead Yale Cancer Center and Smilow Cancer Hospital
​​Katrina Goddard named director of NCI’s Division of Cancer Control and Population Sciences
Robert Winn, Judy Garber, Sidney and Caroline Kimmel, Robert Croyle receive awards and honors at AACI/CCAF Annual Meeting
Antwione Haywood named IU Simon CCC’s first associate director of DEI
NCI renews ‘comprehensive’ designation for UC Davis Comprehensive Cancer Center
Marcia Brose joins SKCC as regional chief of cancer services for Jefferson Health Northeast Division

Drugs & Targets

Keytruda + chemo gets EC approval for locally recurrent unresectable or metastatic triple-negative breast cancer
Opdivo + chemo gets EC approval for metastatic gastric cancer, GEJ cancer, or EAC
Point32Health, Takeda enter risk-sharing agreement for Alunbrig in ALK+NSCLC
FDA approval makes Tecentriq the first adjuvant treatment for NSCLC
Verzenio with endocrine therapy gets FDA approval for early breast cancer
Keytruda combination gets FDA approval for first-line cervical cancer treatment

In The Clinic

Trials & Tribulations

A FLASH flood of research relating to ultra-high dose rate radiation therapy

A FLASH flood of research relating to ultra-high dose rate radiation therapy
Converting Cox hazard ratios with Cox-TEL to improve interpretation of drug efficacy in checkpoint inhibitor trials
Trials & Tribulations
Rogue drug maker first inflates the price of lomustine, then says No to Medicare coverage
Trials & Tribulations
Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA
Trials & Tribulations
Precision oncology must evolve to address health disparities
FreeTrials & Tribulations

Latest Issue

Read the latest issue
DOWNLOAD THE PDF

UPCOMING EVENTS

There are no upcoming events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?